215 related articles for article (PubMed ID: 37684667)
1. Enhanced therapeutic effect of PEDF-loaded mesenchymal stem cell-derived small extracellular vesicles against oxygen-induced retinopathy through increased stability and penetrability of PEDF.
Fan R; Su L; Zhang H; Jiang Y; Yu Z; Zhang X; Li X
J Nanobiotechnology; 2023 Sep; 21(1):327. PubMed ID: 37684667
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.
Sheibani N; Zaitoun IS; Wang S; Darjatmoko SR; Suscha A; Song YS; Sorenson CM; Shifrin V; Albert DM; Melgar-Asensio I; Kandela I; Henkin J
Exp Eye Res; 2020 Jun; 195():108030. PubMed ID: 32272114
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.
Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME
Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387
[TBL] [Abstract][Full Text] [Related]
4. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y
Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles secreted from mesenchymal stem cells exert anti-apoptotic and anti-inflammatory effects via transmitting microRNA-18b in rats with diabetic retinopathy.
Xu Z; Tian N; Li S; Li K; Guo H; Zhang H; Jin H; An M; Yu X
Int Immunopharmacol; 2021 Dec; 101(Pt B):108234. PubMed ID: 34655847
[TBL] [Abstract][Full Text] [Related]
6. MSC-Derived Small Extracellular Vesicles Alleviate Diabetic Retinopathy by Delivering miR-22-3p to Inhibit NLRP3 Inflammasome Activation.
Chen Y; Yao G; Tong J; Xie H; Zheng X; Zhang H; Xie Z
Stem Cells; 2024 Jan; 42(1):64-75. PubMed ID: 37847598
[TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
8. Small interference RNA targeting vascular endothelial growth factor gene effectively attenuates retinal neovascularization in mice model.
Kong YC; Sun B; Zhao KX; Han M; Wang YC
Chin Med J (Engl); 2013; 126(8):1440-4. PubMed ID: 23595374
[TBL] [Abstract][Full Text] [Related]
9. Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy.
Reddy SK; Ballal AR; Shailaja S; Seetharam RN; Raghu CH; Sankhe R; Pai K; Tender T; Mathew M; Aroor A; Shetty AK; Adiga S; Devi V; Muttigi MS; Upadhya D
Theranostics; 2023; 13(7):2241-2255. PubMed ID: 37153730
[TBL] [Abstract][Full Text] [Related]
10. PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation.
Elayappan B; Ravinarayannan H; Pasha SP; Lee KJ; Gurunathan S
Angiogenesis; 2009; 12(4):313-24. PubMed ID: 19657716
[TBL] [Abstract][Full Text] [Related]
11. Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1α/EZH2/PGC-1α pathway.
Sun F; Sun Y; Wang X; Zhu J; Chen S; Yu Y; Zhu M; Xu W; Qian H
Bioact Mater; 2024 Mar; 33():444-459. PubMed ID: 38076648
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
13. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
Werdich XQ; McCollum GW; Rajaratnam VS; Penn JS
Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.
Park K; Jin J; Hu Y; Zhou K; Ma JX
Am J Pathol; 2011 Feb; 178(2):688-98. PubMed ID: 21281801
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4.
Sun F; Sun Y; Zhu J; Wang X; Ji C; Zhang J; Chen S; Yu Y; Xu W; Qian H
Stem Cell Res Ther; 2022 Jul; 13(1):293. PubMed ID: 35841055
[TBL] [Abstract][Full Text] [Related]
16. MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia.
Wei Y; Wu Y; Zhao R; Zhang K; Midgley AC; Kong D; Li Z; Zhao Q
Biomaterials; 2019 Jun; 204():13-24. PubMed ID: 30875515
[TBL] [Abstract][Full Text] [Related]
17. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
[TBL] [Abstract][Full Text] [Related]
18. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.
Al-Shabrawey M; Mussell R; Kahook K; Tawfik A; Eladl M; Sarthy V; Nussbaum J; El-Marakby A; Park SY; Gurel Z; Sheibani N; Maddipati KR
Diabetes; 2011 Feb; 60(2):614-24. PubMed ID: 21228311
[TBL] [Abstract][Full Text] [Related]
19. [The protective effect of pigment epithelial-derived factor modified human umbilical cord mesenchymal stem cells on rats with diabetic retinopathy].
Zhang W; Duan HT; Chen S; Wang YX; Kong JH; Dong M; Bi X; Song J
Zhonghua Yan Ke Za Zhi; 2017 Jul; 53(7):540-547. PubMed ID: 28728289
[No Abstract] [Full Text] [Related]
20. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
